Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jul;23(7):1343-5.
doi: 10.1038/leu.2009.59. Epub 2009 Mar 19.

Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML

Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML

A Tefferi et al. Leukemia. 2009 Jul.
No abstract available

PubMed Disclaimer

References

    1. Delhommeau F, Dupont S, James C, Masse A, le Couedic JP, Valle VD, et al. TET2 is a novel tumor suppressor gene inactivated in myeloproliferative neoplasms: identification of a Pre-JAK2 V617F event. ASH Annual Meeting Abstracts. 2008;112:lba-3. Late-Breaking Abstract.
    1. Tefferi A, Pardanani A, Lim KH, Abdel-Wahab O, Lasho TL, Patel J, et al. TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis. Leukemia. 2009 doi: 10.1038/leu.2009.47. advance online publication, 5 March 2009. - DOI - PMC - PubMed
    1. Tefferi A, Levine RL, Lim KH, Abdel-Wahab O, Lasho TL, Patel J, et al. Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates. Leukemia. 2009 doi: 10.1038/leu.2009.37.. advance online publication, 5 March 2009. - DOI - PMC - PubMed
    1. Tefferi A, Vardiman JW. Classification and diagnosis of myelopro-liferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia. 2008;22:14–22. - PubMed
    1. Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization Classification of Tumours of Hematopoietic and Lymphoid Tissues. IARC Press; Lyon, France: 2001. pp. 1–351.